Table 1.
Characteristics of COVID-19 Patients
| Non-COVID-19 | Non-COVID-19 Pneumonia | Disease Severity |
|||
|---|---|---|---|---|---|
| COVID-19 Control | ARDS | p Value | |||
| Number of patients | 10 | 3 | 35 (77.8%) | 10 (22.2%) | – |
| Available follow-up data | n.a. | n.a. | 22 (62.9%) | 4 (40%) | 0.281 |
| Time after PCR diagnosis of initial visit (days) | n.a. | n.a. | 2 [1–3] | 7 [3–10] | 0.015 |
| Time after PCR diagnosis of follow-up visit (days) | n.a. | n.a. | 8 [6–15] | 31 [29–32] | 0.003 |
| Age (years) | 55 [51–57] | 51 [32–70] | 65 [57–81] | 58 [48–74] | 0.199 |
| Sex (male/female) | 5/5 (50.0%/50.0%) | 2/1 (66.7%/33.3%) | 17/18 (48.6%/51.4%) | 10/0 (100.0%/0.0%) | 0.003 |
| Comorbidities | |||||
| Cancer | 0.0 (0.0%) | n.a. | 10 (28.6%) | 1 (10.0%) | 0.409 |
| Chronic renal disease | 0.0 (0.0%) | n.a. | 6 (17.1%) | 0 (0.0%) | 0.312 |
| Obstructive lung disease | n.a. | n.a. | 3 (8.6%) | 0 (0.0%) | 1.000 |
| Diabetes | 0.0 (0.0%) | n.a. | 9 (25.7%) | 1 (10.0%) | 0.415 |
| Cardiovascular disease | 0.0 (0.0%) | n.a. | 21 (60.0%) | 5 (50.0%) | 0.720 |
The p value refers to the comparison between the ARDS and the COVID-19 control sub-cohorts. Quantitative variables are expressed as median (interquartile range [IQR]) and compared by the Mann-Whitney test. Categorical variables were compared using Fisher’s exact test. n.a., not applicable.